1. Home
  2. PKST vs EOLS Comparison

PKST vs EOLS Comparison

Compare PKST & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PKST
  • EOLS
  • Stock Information
  • Founded
  • PKST 2008
  • EOLS 2012
  • Country
  • PKST United States
  • EOLS United States
  • Employees
  • PKST N/A
  • EOLS N/A
  • Industry
  • PKST Real Estate Investment Trusts
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PKST Real Estate
  • EOLS Health Care
  • Exchange
  • PKST Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • PKST 470.2M
  • EOLS 406.9M
  • IPO Year
  • PKST N/A
  • EOLS 2018
  • Fundamental
  • Price
  • PKST $12.87
  • EOLS $6.04
  • Analyst Decision
  • PKST Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • PKST 2
  • EOLS 4
  • Target Price
  • PKST $17.50
  • EOLS $21.25
  • AVG Volume (30 Days)
  • PKST 215.6K
  • EOLS 1.0M
  • Earning Date
  • PKST 10-29-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • PKST 3.13%
  • EOLS N/A
  • EPS Growth
  • PKST N/A
  • EOLS N/A
  • EPS
  • PKST N/A
  • EOLS N/A
  • Revenue
  • PKST $223,891,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • PKST N/A
  • EOLS $13.68
  • Revenue Next Year
  • PKST N/A
  • EOLS $27.96
  • P/E Ratio
  • PKST N/A
  • EOLS N/A
  • Revenue Growth
  • PKST N/A
  • EOLS 17.15
  • 52 Week Low
  • PKST $10.14
  • EOLS $5.71
  • 52 Week High
  • PKST $14.80
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • PKST 41.10
  • EOLS 35.36
  • Support Level
  • PKST $12.80
  • EOLS $5.92
  • Resistance Level
  • PKST $13.73
  • EOLS $6.42
  • Average True Range (ATR)
  • PKST 0.41
  • EOLS 0.22
  • MACD
  • PKST -0.07
  • EOLS 0.04
  • Stochastic Oscillator
  • PKST 25.75
  • EOLS 30.82

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: